Dapoxetine isn’t technically banned in the United States. It was never approved. In 2005, the FDA issued a “not approvable” letter to the company seeking to bring it to market, and no manufacturer has successfully resubmitted it since. The result is the same from a consumer’s perspective: you can’t get a prescription for dapoxetine in the US, even though it’s legally available in dozens of other countries.
What Happened With the FDA Application
Dapoxetine was developed as an on-demand treatment for premature ejaculation, marketed under the brand name Priligy in other countries. ALZA Corporation, a subsidiary of Johnson & Johnson, submitted a new drug application to the FDA. In October 2005, the FDA responded with a “not approvable” letter, which signals that the agency wasn’t satisfied with the application as submitted.
The FDA did not publicly detail every reason for the decision, but the general concern centered on the drug’s safety profile relative to its intended use. Premature ejaculation, while distressing, is not a life-threatening condition. That raises the bar for acceptable side effects. The most common adverse reactions in clinical trials included nausea (about 9%), headache (4.4%), diarrhea (3.6%), and dizziness (2.4%). There were also concerns about fainting episodes and interactions with other medications. For a drug you’d take before sex rather than to treat a serious disease, the FDA applies a stricter risk-benefit calculation.
After receiving the letter, Johnson & Johnson did not resubmit a revised application. No other company has picked up the effort in the nearly two decades since.
How Dapoxetine Differs From Other SSRIs
Dapoxetine belongs to the same drug class as antidepressants like paroxetine and fluoxetine. These medications increase serotonin activity in the brain, which as a side effect tends to delay ejaculation. That side effect is actually the whole point with dapoxetine, but its design is fundamentally different from traditional antidepressants.
Standard SSRIs take weeks to build up in your system and are meant to be taken daily. Dapoxetine works fast and clears out fast. It reaches peak levels in your blood about one to one and a quarter hours after you take it, and its half-life is only about 1.3 to 1.4 hours. That means the drug is largely out of your system within a few hours. This rapid on-and-off profile makes it practical as a pill you take a couple hours before sex rather than every morning.
That same rapid action, though, may have contributed to the FDA’s hesitation. Quick spikes and drops in serotonin can produce more noticeable side effects like dizziness and nausea compared to the slow, steady buildup of a daily SSRI.
Where Dapoxetine Is Approved
The European Medicines Agency evaluated dapoxetine around 2008, and it eventually became available as Priligy in several European countries. It’s also approved in Mexico, South Korea, New Zealand, and other markets. As of the most recent counts, it has been licensed in dozens of countries worldwide. In these markets, it’s typically prescribed as a 30 mg or 60 mg tablet taken one to three hours before sexual activity.
Clinical trials that supported these approvals showed meaningful improvements in ejaculatory control and patient satisfaction. A large study also found that men taking dapoxetine alongside common erectile dysfunction medications tolerated the combination reasonably well, with side effects that were mostly mild and consistent with what dapoxetine causes on its own.
What US Doctors Prescribe Instead
The lack of an approved on-demand option in the US hasn’t left men without treatment. The American Urological Association recommends daily SSRIs and topical numbing agents as first-line treatments for premature ejaculation. Notably, the AUA’s own guidelines list dapoxetine as a recommended option “where available,” acknowledging its effectiveness while recognizing it simply isn’t accessible in the US.
The SSRIs most commonly prescribed off-label for premature ejaculation include paroxetine, sertraline, fluoxetine, and citalopram. These are all taken daily. Of the group, paroxetine tends to produce the strongest ejaculatory delay. Clomipramine, an older tricyclic antidepressant, is another option that can be used either daily or on demand a few hours before intercourse.
Some doctors prescribe these SSRIs on an as-needed basis, taken three to six hours before sex. This approach works, but research consistently shows it produces less ejaculatory delay than daily dosing. It’s a trade-off: daily pills work better but expose you to a medication every day for what may be an occasional concern.
Topical anesthetics applied to the penis before sex offer another route entirely. These creams or sprays reduce sensitivity directly and avoid the systemic side effects of oral medications. Some formulations are available over the counter.
Why No One Has Tried Again
The simplest explanation for dapoxetine’s continued absence from the US market is economics. Resubmitting to the FDA would likely require new or additional clinical trials to address whatever safety concerns prompted the original rejection. That process costs hundreds of millions of dollars. Meanwhile, doctors already prescribe existing SSRIs off-label for the same condition, which limits the commercial upside of bringing a dedicated product to market. Generic versions of paroxetine and sertraline cost very little, making it hard for a branded drug like Priligy to compete on price even if it were approved.
The condition itself also carries a stigma that may reduce the number of men willing to seek a prescription, further shrinking the potential market. For pharmaceutical companies doing the math, the investment required to clear FDA approval simply may not pencil out when cheaper alternatives already exist and the patient population is smaller than it might appear on paper.